Jeonjinbio Co. Ltd (110020) - Total Assets
Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) holds total assets worth ₩19.00 Billion KRW (≈ $12.87 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 110020 net assets for net asset value and shareholders' equity analysis.
Jeonjinbio Co. Ltd - Total Assets Trend (2015–2024)
This chart illustrates how Jeonjinbio Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Jeonjinbio Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Jeonjinbio Co. Ltd's total assets of ₩19.00 Billion consist of 53.8% current assets and 46.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩6.28 Billion | 0.0% |
| Accounts Receivable | ₩2.45 Billion | 13.0% |
| Inventory | ₩921.32 Million | 4.9% |
| Property, Plant & Equipment | ₩8.69 Billion | 46.1% |
| Intangible Assets | ₩21.76 Million | 0.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Jeonjinbio Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Jeonjinbio Co. Ltd (110020) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jeonjinbio Co. Ltd's current assets represent 53.8% of total assets in 2024, a decrease from 80.6% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 12.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 46.1% of total assets.
Jeonjinbio Co. Ltd Competitors by Total Assets
Key competitors of Jeonjinbio Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Air Products and Chemicals Inc
NYSE:APD
|
USA | $41.24 Billion |
|
Akzo Nobel NV
AS:AKZA
|
Netherlands | €13.95 Billion |
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
|
Germany | €13.95 Billion |
|
Incitec Pivot Ltd
AU:IPL
|
Australia | AU$8.40 Billion |
|
Shandong Head Co Ltd
SHE:002810
|
China | CN¥4.07 Billion |
|
Boai NKY Pharmaceuticals Ltd
SHE:300109
|
China | CN¥4.24 Billion |
|
Shen Ma Industry Co Ltd
SHG:600810
|
China | CN¥29.52 Billion |
|
Anhui Guofeng Plastic Industry Co Ltd
SHE:000859
|
China | CN¥4.56 Billion |
Jeonjinbio Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.77 | 4.98 | 1.36 |
| Quick Ratio | 7.64 | 4.18 | 1.31 |
| Cash Ratio | 0.00 | 2.60 | 0.00 |
| Working Capital | ₩8.70 Billion | ₩8.12 Billion | ₩2.64 Billion |
Jeonjinbio Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Jeonjinbio Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.02 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.5% |
| Total Assets | ₩18.85 Billion |
| Market Capitalization | $14.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jeonjinbio Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Jeonjinbio Co. Ltd's assets grew by 6.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Jeonjinbio Co. Ltd (2015–2024)
The table below shows the annual total assets of Jeonjinbio Co. Ltd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩18.85 Billion ≈ $12.78 Million |
+6.49% |
| 2023-12-31 | ₩17.70 Billion ≈ $12.00 Million |
-0.92% |
| 2022-12-31 | ₩17.87 Billion ≈ $12.11 Million |
-28.00% |
| 2021-12-31 | ₩24.82 Billion ≈ $16.82 Million |
+32.75% |
| 2020-12-31 | ₩18.69 Billion ≈ $12.67 Million |
+191.61% |
| 2019-12-31 | ₩6.41 Billion ≈ $4.34 Million |
-9.96% |
| 2018-12-31 | ₩7.12 Billion ≈ $4.83 Million |
+75.48% |
| 2017-12-31 | ₩4.06 Billion ≈ $2.75 Million |
-30.41% |
| 2016-12-31 | ₩5.83 Billion ≈ $3.95 Million |
-36.72% |
| 2015-12-31 | ₩9.21 Billion ≈ $6.24 Million |
-- |
About Jeonjinbio Co. Ltd
Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more